Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,250 | 1 | 41.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,830 | 1 | 34.0% |
| Travel and Lodging | $953.85 | 2 | 17.7% |
| Food and Beverage | $251.67 | 3 | 4.7% |
| Education | $99.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,812 | 4 | $0 (2023) |
| Karyopharm Therapeutics Inc. | $2,250 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $203.75 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $118.57 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,812 | 4 | PFIZER INC. ($2,812) |
| 2021 | $2,572 | 4 | Karyopharm Therapeutics Inc. ($2,250) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2023 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,830.00 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $505.68 | General |
| 08/23/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $448.17 | General |
| 08/23/2023 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $118.57 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 06/29/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $104.75 | General |
| Category: Oncology | ||||||
| 06/15/2021 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
About Alexandra Distaso, FNP-BC
Alexandra Distaso, FNP-BC is a Family healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710367560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexandra Distaso, FNP-BC has received a total of $5,385 in payments from pharmaceutical and medical device companies, with $2,812 received in 2023. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,250).
Practice Information
- Specialty Family
- Location Boston, MA
- Active Since 06/08/2015
- Last Updated 05/06/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710367560
Products in Payments
- XPOVIO (Drug) $2,250
- ELREXFIO (Drug) $1,858
- BLENREP (Biological) $118.57
- DARZALEX (Biological) $104.75
- IMBRUVICA (Drug) $99.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Boston
Brittany Murray, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Family — Payments: $91,393
Ms. Naomi Amudala, Np, NP
Family — Payments: $40,295
Mrs. Alexa Costa, Np-C, NP-C
Family — Payments: $16,778
Caitlin Murphy, Dnp, DNP
Family — Payments: $15,757
Lauren Camillieri, Fnp-Bc, FNP-BC
Family — Payments: $7,681
Charlene Sylvestre, N.p, N.P
Family — Payments: $6,498